Founded in 2018, Carlsmed focuses on transforming spine surgery through its digital-to-device aprevo technology platform. The platform creates a virtual 3D model of a patient's pathology to generate an optimal surgical plan, which is then used to manufacture custom-built, anatomically designed vertebral interbody implants on demand. The company currently markets its solutions for both lumbar and cervical spine fusion surgeries. By providing personalized implants and single-use surgical instruments, Carlsmed aims to reduce revision rates and improve alignment predictability compared to standard-sized implants. The company primarily serves hospitals and ambulatory surgical centers across the United States.
